Transcriptome networks identify mechanisms of viral and nonviral asthma exacerbations in children

Nature Immunology

Volumn 20, Issue 5, 2019, Pages 637-651

  Altman, Matthew C ^a,b   Gill, Michelle A ^c   Whalen, Elizabeth ^b   Babineau, Denise C ^d   Shao, Baomei ^c   Liu, Andrew H ^e   Jepson, Brett ^d   Gruchalla, Rebecca S ^c   O’Connor, George T ^f   Pongracic, Jacqueline A ^g   Kercsmar, Carolyn M ^h   Khurana Hershey, Gurjit K ^h   Zoratti, Edward M ⁱ   Johnson, Christine C ⁱ   Teach, Stephen J ^j   Kattan, Meyer ^k   Bacharier, Leonard B ^l   Beigelman, Avraham ^l   Sigelman, Steve M ^m   Presnell, Scott ^b   Gern, James E ⁿ   Gergen, Peter J ^m   Wheatley, Lisa M ^m   Togias, Alkis ^m   Busse, William W ⁿ   Jackson, Daniel J ⁿ   more..

^a UNIVERSITY OF WASHINGTON   (United States)

^b BENAROYA RESEARCH INSTITUTE   (United States)

^c UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^d RHO INC   (United States)

^e UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^f BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^g CHILDREN'S MEMORIAL HOSPITAL   (United States)

^h CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

ⁱ HENRY FORD HEALTH SYSTEM   (United States)

^j CHILDREN'S NATIONAL MEDICAL CENTER   (United States)

^k Columbia University College of Physicians and Surgeons ^*  (United States)

^l WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^m NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

ⁿ UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR; FLUTICASONE; FLUTICASONE PROPIONATE PLUS SALMETEROL XINAFOATE; SMAD3 PROTEIN; TRANSCRIPTOME;

ADOLESCENT; ARTICLE; ASTHMA; BASOPHIL; CASE CONTROL STUDY; CHILD; COMMON COLD; COMMON COLD SYMPTOM; CORONAVIRUS INFECTION; CORTICOSTEROID THERAPY; DISEASE EXACERBATION; DISEASE SEVERITY; EOSINOPHIL; FEMALE; FORCED EXPIRATORY VOLUME; FRACTIONAL EXHALED NITRIC OXIDE; HUMAN; INFLUENZA B; LONGITUDINAL STUDY; LYMPHOCYTE; LYMPHOCYTE ACTIVATION; MAJOR CLINICAL STUDY; MALE; METAPNEUMOVIRUS INFECTION; MUCUS SECRETION; NASAL LAVAGE; NEUTROPHIL; NOSE EPITHELIUM; PARAINFLUENZA VIRUS INFECTION; PEDIATRICS; PRIORITY JOURNAL; PROSPECTIVE STUDY; RNA SEQUENCE; GENE REGULATORY NETWORK; GENETICS; IMMUNOLOGY; SIGNAL TRANSDUCTION; VIROLOGY; VIRUS INFECTION;

ADOLESCENT; ASTHMA; CASE-CONTROL STUDIES; CHILD; COMMON COLD; FEMALE; GENE REGULATORY NETWORKS; HUMANS; LONGITUDINAL STUDIES; MALE; PROSPECTIVE STUDIES; SIGNAL TRANSDUCTION; TRANSCRIPTOME; VIRUS DISEASES;

EID: 85064074102     PISSN: 15292908     EISSN: 15292916     Source Type: Journal    
DOI: 10.1038/s41590-019-0347-8     Document Type: Article

References (66)

1. Johnston, S. L. et al. Community study of role of viral infections in exacerbations of asthma in 9–11 year old children. BMJ 310, 1225–1229 (1995).
2. Busse, W. W., Lemanske, R. F. Jr & Gern, J. E. Role of viral respiratory infections in asthma and asthma exacerbations. Lancet 376, 826–834 (2010).
3. Olenec, J. P. et al. Weekly monitoring of children with asthma for infections and illness during common cold seasons. J. Allergy Clin. Immunol. 125, 1001–1006 (2010).
4. Busse, W. W. et al. Randomized trial of omalizumab (anti-IgE) for asthma in inner-city children. N. Engl. J. Med. 364, 1005–1015 (2011).
5. Pavord, I. D. et al. Mepolizumab for severe eosinophilic asthma (DREAM): a multicentre, double-blind, placebo-controlled trial. Lancet 380, 651–659 (2012).
6. Castro, M. et al. Dupilumab efficacy and safety in moderate-to-severe uncontrolled asthma. N. Engl. J. Med. 378, 2486–2496 (2018).
7. Drazen, J. M. & Harrington, D. New biologics for asthma. N. Engl. J. Med. 378, 2533–2534 (2018).
8. Jackson, D. J. et al. IL-33-dependent type 2 inflammation during rhinovirus-induced asthma exacerbations in vivo. Am. J. Respir. Crit. Care Med. 190, 1373–1382 (2014).
9. Farne, H. A. & Johnston, S. L. Immune mechanisms of respiratory viral infections in asthma. Curr. Opin. Immunol. 48, 31–37 (2017).
10. Chaussabel, D. & Baldwin, N. Democratizing systems immunology with modular transcriptional repertoire analyses. Nat. Rev. Immunol. 14, 271–280 (2014).
11. Woodruff, P. G. et al. Genome-wide profiling identifies epithelial cell genes associated with asthma and with treatment response to corticosteroids. Proc. Natl Acad. Sci. USA 104, 15858–15863 (2007).
12. Bosco, A., Ehteshami, S., Panyala, S. & Martinez, F. D. Interferon regulatory factor 7 is a major hub connecting interferon-mediated responses in virus-induced asthma exacerbations in vivo. J. Allergy Clin. Immunol. 129, 88–94 (2012).
13. Wesolowska-Andersen, A. et al. Dual RNA-seq reveals viral infections in asthmatic children without respiratory illness which are associated with changes in the airway transcriptome. Genome Biol. 18, 12 (2017).
14. Berube, J. C. & Bosse, Y. Future clinical implications emerging from recent genome-wide expression studies in asthma. Expert Rev. Clin. Immunol. 10, 985–1004 (2014).
15. Bonser, L. R. & Erle, D. J. Airway mucus and asthma: the role of MUC5AC and MUC5B. J. Clin. Med. 6, E112 (2017).
16. Paul, M. K. et al. Dynamic changes in intracellular ROS levels regulate airway basal stem cell homeostasis through Nrf2-dependent Notch signaling. Cell Stem Cell 15, 199–214 (2014).
17. Kim, J. T., Gleich, G. J. & Kita, H. Roles of CD9 molecules in survival and activation of human eosinophils. J. Immunol. 159, 926–933 (1997).
18. Gudbjartsson, D. F. et al. Sequence variants affecting eosinophil numbers associate with asthma and myocardial infarction. Nat. Genet. 41, 342–347 (2009).
19. Loffredo, L. F. et al. Beyond epithelial-to-mesenchymal transition: common suppression of differentiation programs underlies epithelial barrier dysfunction in mild, moderate, and severe asthma. Allergy 72, 1988–2004 (2017).
20. Reeves, S. R. et al. Asthmatic airway epithelial cells differentially regulate fibroblast expression of extracellular matrix components. J. Allergy Clin. Immunol. 134, 63–670 (2014).
21. Hamid, Q. et al. Induction of nitric oxide synthase in asthma. Lancet 342, 1510–1513 (1993).
22. Coulthard, M. G. et al. Eph/Ephrin signaling in injury and inflammation. Am. J. Pathol. 181, 1493–1503 (2012).
23. Amishima, M. et al. Expression of epidermal growth factor and epidermal growth factor receptor immunoreactivity in the asthmatic human airway. Am. J. Respir. Crit. Care Med. 157, 1907–1912 (1998).
24. Takeyama, K., Fahy, J. V. & Nadel, J. A. Relationship of epidermal growth factor receptors to goblet cell production in human bronchi. Am. J. Respir. Crit. Care Med. 163, 511–516 (2001).
25. Bigler, J. et al. A severe asthma disease signature from gene expression profiling of peripheral blood from U-BIOPRED cohorts. Am. J. Respir. Crit. Care Med. 195, 1311–1320 (2017).
26. Kuo, C.-H. S. et al. A transcriptome-driven analysis of epithelial brushings and bronchial biopsies to define asthma phenotypes in U-BIOPRED. Am. J. Respir. Crit. Care Med. 195, 443–455 (2017).
27. Persson, H. et al. Transcriptome analysis of controlled and therapy-resistant childhood asthma reveals distinct gene expression profiles. J. Allergy Clin. Immunol. 136, 638–648 (2015).
28. Sordillo, J. E. et al. Genome-wide expression profiles identify potential targets for gene–environment interactions in asthma severity. J. Allergy Clin. Immunol. 136, 885–892 (2015).
29. Subrata, L. S. et al. Interactions between innate antiviral and atopic immunoinflammatory pathways precipitate and sustain asthma exacerbations in children. J. Immunol. 183, 2793–2800 (2009).
30. Poole, A. et al. Dissecting childhood asthma with nasal transcriptomics distinguishes subphenotypes of disease. J. Allergy Clin. Immunol. 133, 670–678 (2014).
31. Al-Alawi, M., Hassan, T. & Chotirmall, S. H. Transforming growth factor β and severe asthma: a perfect storm. Respir. Med. 108, 1409–1423 (2014).
32. Le, A. V. et al. Inhibition of allergen-induced airway remodeling in Smad 3-deficient mice. J. Immunol. 178, 7310–7316 (2007).
33. O’Byrne, P. M., Pedersen, S., Lamm, C. J., Tan, W. C. & Busse, W. W. Severe exacerbations and decline in lung function in asthma. Am. J. Respir. Crit. Care Med. 179, 19–24 (2009).
34. Holgate, S. T. et al. Asthma. Nat. Rev. Dis. Primers 1, 15025 (2015).
35. Liew, F. Y., Girard, J. P. & Turnquist, H. R. Interleukin-33 in health and disease. Nat. Rev. Immunol. 16, 676–689 (2016).
36. Oboki, K. et al. IL-33 is a crucial amplifier of innate rather than acquired immunity. Proc. Natl Acad. Sci. USA 107, 18581–18586 (2010).
37. Polumuri, S. K. et al. Transcriptional regulation of murine IL-33 by TLR and non-TLR agonists. J. Immunol. 189, 50–60 (2012).
38. Bonnelykke, K. et al. A genome-wide association study identifies CDHR3 as a susceptibility locus for early childhood asthma with severe exacerbations. Nat. Genet. 46, 51–55 (2014).
39. Coggins, C. R. A review of chronic inhalation studies with mainstream cigarette smoke in rats and mice. Toxicol. Pathol. 26, 307–314 (1998).
40. Ricciaolo, F. L. M. et al. Expression of vascular remodelling markers in relation to bradykinin receptors in asthma and COPD. Thorax 68, 803–811 (2013).
41. Ricciardolo, F. L. M., Folkerts, G., Folino, A. & Mognetti, B. Bradykinin in asthma: modulation of airway inflammation and remodelling. Eur. J. Pharmacol. 827, 181–188 (2018).
42. Ricciardolo, F. L. M. et al. Bronchoconstriction induced by citric acid inhalation in guinea pigs. Am. J. Respir. Crit. Care Med. 159, 557–562 (1999).
43. Christiansen, S. C. et al. Elevation of tissue kallikrein and kinin in the airways of asthmatic subjects after endobronchial allergen challenge. Am. Rev. Respir. Dis. 145, 900–905 (1992).
44. Wark, P. A. B. et al. Asthmatic bronchial epithelial cells have a deficient innate immune response to infection with rhinovirus. J. Exp. Med. 201, 937–947 (2005).
45. Zhu, J. et al. Bronchial mucosal IFN-α/β and pattern recognition receptor expression in patients with experimental rhinovirus-induced asthma exacerbations. J. Allergy Clin. Immunol. 143, 114–125 (2019).
46. Patel, D. A. et al. Interferon response and respiratory virus control are preserved in bronchial epithelial cells in asthma. J. Allergy Clin. Immunol. 134, 1402–1412 (2014).
47. Altman, M. C. et al. Interferon response to respiratory syncytial virus by bronchial epithelium from children with asthma is inversely correlated with pulmonary function. J. Allergy Clin. Immunol. 142, 451–459 (2018).
48. Durrani, S. R., Viswanathan, R. K. & Busse, W. W. What effect does asthma treatment have on airway remodeling? Current perspectives. J. Allergy Clin. Immunol. 128, 439–448 (2011).
49. Lopez-Guisa, J. M. et al. Airway epithelial cells from asthmatic children differentially express proremodeling factors. J. Allergy Clin. Immunol. 129, 990–997 (2012).
50. Mihaylova, V. T. et al. Regional differences in airway epithelial cells reveal tradeoff between defense against oxidative stress and defense against rhinovirus. Cell Rep. 24, 3000–3007 (2018).
51. Expert Panel Report 3 (EPR-3): Guidelines for the Diagnosis and Management of Asthma—Summary Report 2007. J. Allergy Clin. Immunol. 120, S94–S138 (2007).
52. Bochkov, Y. A., Grindle, K., Vang, F., Evans, M. D. & Gern, J. E. Improved molecular typing assay for rhinovirus species A, B, and C. J. Clin. Microbiol. 52, 2461–2471 (2014).
53. Kloepfer, K. M. et al. Increased H1N1 infection rate in children with asthma. Am. J. Respir. Crit. Care Med. 185, 1275–1279 (2012).
54. Fahy, J. V. et al. Safety and reproducibility of sputum induction in asthmatic subjects in a multicenter study. Am. J. Respir. Crit. Care Med. 163, 1470–1475 (2001).
55. Trapnell, C., Pachter, L. & Salzberg, S. L. TopHat: discovering splice junctions with RNA-Seq. Bioinformatics 25, 1105–1111 (2009).
56. Anders, S., Pyl, P. T. & Huber, W. HTSeq—a Python framework to work with high-throughput sequencing data. Bioinformatics 31, 166–169 (2015).
57. Smedley, D. et al. The BioMart community portal: an innovative alternative to large, centralized data repositories. Nucleic Acids Res. 43, W589–W598 (2015).
58. Liu, R. et al. Why weight? Modelling sample and observational level variability improves power in RNA-seq analyses. Nucleic Acids Res. 43, e97 (2015).
59. Ritchie, M. E. et al. limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Res. 43, e47 (2015).
60. Chikina, M., Zaslavsky, E. & Sealfon, S. C. CellCODE: a robust latent variable approach to differential expression analysis for heterogeneous cell populations. Bioinformatics 31, 1584–1591 (2015).
61. Langfelder, P. & Horvath, S. WGCNA: an R package for weighted correlation network analysis. BMC Bioinformatics 9, 559 (2008).
62. Huang, D. W., Sherman, B. T. & Lempicki, R. A. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat. Protoc. 4, 44–57 (2009).
63. Huang, W. D., Sherman, B. T. & Lempicki, R. A. Bioinformatics enrichment tools: paths toward the comprehensive functional analysis of large gene lists. Nucleic Acids Res. 37, 1–13 (2009).
64. Snel, B. STRING: a web-server to retrieve and display the repeatedly occurring neighbourhood of a gene. Nucleic Acids Res. 28, 3442–3444 (2000).
65. Szklarczyk, D. et al. STRINGv10: protein–protein interaction networks, integrated over the tree of life. Nucleic Acids Res. 43, D447–D452 (2015).
66. Shannon, P. et al. Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Res. 13, 2498–2504 (2003).